FDA approves Ambio’s generic version of Forteo developed in collaboration with Apotex
Ambio, Inc., a leader in biotech innovation specializing in peptide drugs and complex generics, has announced that its generic version of Forteo (teriparatide injection), developed in collaboration with Apotex, has received approval from the U.S. Food and Drug Administration (FDA). Ambio’s Technological Prowess in Peptide Development Simrat Singh, President of Ambio, Inc., highlighted the company’s […]